Table 1.
Baseline demographic and clinical profiles
| Completed ( n = 22) | Withdrawn ( n = 7) | P a | |
|---|---|---|---|
| Sex (male/female) | 10/12 | 3/4 | 0.59 |
| Age, year | 52.1 (14.4) | 46.5 (14.1) | 0.49 |
| Clinical subtype | 0.49 | ||
| Paranoid | 18 | 7 | |
| Disorganized | 1 | 0 | |
| Catatonic | 1 | 0 | |
| Residual | 2 | 0 | |
| Reason for switching | 0.60 | ||
| Treatment resistant | 13 | 3 | |
| Treatment intolerant | 5 | 3 | |
| Resistant and intolerant | 4 | 1 | |
| Education, year | |||
| Subject | 12.9 (1.8) | 13.0 (1.0) | 0.59 |
| Father | 12.3 (2.6) | 10.5 (1.9) | 0.28 |
| Mother | 12.0 (2.6) | 10.0 (1.7) | 0.25 |
| Previous antipsychotics | 0.13 | ||
| Haloperidol | 5 | 3 | |
| Risperidone | 12 | 4 | |
| Others | 5 | 0 | |
| Average dose of previous antipsychotics (mg/day) | 445.9 (230.6) | 409.2 (303.8) | 0.63 |
Values are expressed as the mean (SD) unless otherwise indicated.
aDifferences in two groups with P values calculated by the Wilcoxon test or the χ 2 test (sex, clinical subtype, reason for switching, and previous antipsychotics).